Section Arrow
CODX.NASDAQ
- Co-Diagnostics Inc.
Quotes are at least 15-min delayed:2026/06/21 07:33 EDT
Regular Hours
Last
 3.37
+0.04 (+1.20%)
Day High 
3.44 
Prev. Close
3.33 
1-M High
13.54 
Volume 
624.11K 
Bid
3.32
Ask
3.43
Day Low
3.1 
Open
3.26 
1-M Low
1.32 
Market Cap 
12.27M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 4.58 
20-SMA 5.53 
50-SMA 3.18 
52-W High 46.5 
52-W Low 1.26 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-32.26/-12.00
Enterprise Value
12.85M
Balance Sheet
Book Value Per Share
4.35
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
622.49K
Operating Revenue Per Share
0.14
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BFLYButterfly Network8.9+3.19+55.87%-- 
ABTAbbott Laboratories88.41-0.09-0.10%24.76PE
TNONTenon Medical Inc0.35-0.2521-41.87%-- 
BSXBoston Scientific Corp45.29+0.34+0.76%18.95PE
MDTMedtronic plc79.34+1.2+1.54%22.16PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.